These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12874508)

  • 41. Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    van Ginkel RJ; Limburg PC; Piers DA; Koops HS; Hoekstra HJ
    Ann Surg Oncol; 2002 May; 9(4):355-63. PubMed ID: 11986187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas.
    Stevenson MG; Seinen JM; Pras E; Brouwers AH; van Ginkel RJ; van Leeuwen BL; Suurmeijer AJH; Been LB; Hoekstra HJ
    J Surg Oncol; 2018 Jun; 117(7):1447-1454. PubMed ID: 29484661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Limb perfusion in soft tissue sarcomas: twenty years of experience].
    Hoven-Gondrie ML; Bastiaannet E; van Ginkel RJ; Pras EB; Suurmeijer A; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2013; 157(30):A6148. PubMed ID: 23890169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma.
    Jakob J; von Rege I; Weiss C; Hohenberger P
    Int J Hyperthermia; 2012; 28(7):591-6. PubMed ID: 22946472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytostatic hyperthermic isolated limb perfusion (HILP) in VFN (General Faculty Hospital in Prague)].
    Spacek M; Mitás P; Lacina L; Krajsová I; Hodková G; Salmay M; Spunda R; Brlicová L; Lindner J
    Rozhl Chir; 2011 Jan; 90(1):62-6. PubMed ID: 21634138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Assessment of regional and systemic toxicity of isolated hyperthermic extremity perfusion with tumor necrosis factor-alpha and melphalan].
    Hohenberger P; Haier J; Kettelhack C; Schulze G; Schlag PM
    Chirurg; 1997 Sep; 68(9):914-20. PubMed ID: 9410682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity.
    Bickels J; Manusama ER; Gutman M; Eggermont AM; Kollender Y; Abu-Abid S; Van Geel AN; Lev-Shlush D; Klausner JM; Meller I
    Eur J Surg Oncol; 1999 Oct; 25(5):509-14. PubMed ID: 10527599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of the drug resistance-associated protein metallothionein does not correlate with response of sarcomas to isolated limb perfusion treatment.
    Grabellus F; Sheu SY; Tötsch M; Lehmann N; Kaiser GM; Jasani B; Taeger G; Schmid KW
    J Surg Oncol; 2010 May; 101(6):465-70. PubMed ID: 20401916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?
    Bonvalot S; Laplanche A; Lejeune F; Stoeckle E; Le Péchoux C; Vanel D; Terrier P; Lumbroso J; Ricard M; Antoni G; Cavalcanti A; Robert C; Lassau N; Blay JY; Le Cesne A
    Ann Oncol; 2005 Jul; 16(7):1061-8. PubMed ID: 15930042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
    Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
    Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolated regional therapy for advanced extremity soft tissue sarcomas.
    Deneve JL; Zager JS
    Surg Oncol Clin N Am; 2012 Apr; 21(2):287-99. PubMed ID: 22365520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy.
    Eggermont AM; ten Hagen TL
    Curr Oncol Rep; 2003 Mar; 5(2):79-80. PubMed ID: 12583823
    [No Abstract]   [Full Text] [Related]  

  • 53. Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.
    Eggermont AM; ten Hagen TL
    Curr Oncol Rep; 2001 Jul; 3(4):359-67. PubMed ID: 11389822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.
    Grunhagen DJ; de Wilt JH; Graveland WJ; Verhoef C; van Geel AN; Eggermont AM
    Cancer; 2006 Apr; 106(8):1776-84. PubMed ID: 16541435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neoadjuvant Hypertermic Isolated Limb Perfusion in Treatment of Undifferentiated Spindle Cell Sarcoma of Lower Limb with Achieved Complete Pathologic Response.
    Vočka M; Špaček M; Matějovský Z; Trnka J; Hodková G; Skibová D; Zogala D; Lindner J; Petruželka L
    Klin Onkol; 2019; 32(3):211-213. PubMed ID: 31216854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [O2 utilization during hyperthermic extremity perfusion with rhTNF alpha and melphalan].
    Haier J; Hohenberger P; Beck K; Schlag PM
    Langenbecks Arch Chir; 1997; 382(3):128-33. PubMed ID: 9324610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
    Cherix S; Speiser M; Matter M; Raffoul W; Liénard D; Theumann N; Mouhsine E; Mirimanoff RO; Leyvraz S; Lejeune FJ; Leyvraz PF
    J Surg Oncol; 2008 Sep; 98(3):148-55. PubMed ID: 18668638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continuous leakage measurement during hyperthermic isolated limb perfusion.
    Daryanani D; Komdeur R; Ter Veen J; Nijhuis PH; Piers DA; Hoekstra HJ
    Ann Surg Oncol; 2001 Aug; 8(7):566-72. PubMed ID: 11508617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    J Clin Oncol; 1996 Feb; 14(2):479-89. PubMed ID: 8636761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept].
    Schwarzbach M; Lehnert T; Willeke F; Hinz U; Herfarth C
    Chirurg; 1996 Dec; 67(12):1237-43. PubMed ID: 9081786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.